Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

The financial sector, like all other parts of the economy, can only evolve and deliver better outcomes for its…

Judith Carr attended TEDxBrum. She was a little surprised and mightily pleased to find so many speakers talking…

The cost of increasing runway capacity in the south east of England is in a steep climb and may yet stall. The…

'Digital only' strategies are marred by the lack of a contact centre to respond when a customer experience goes…

As Hyundai launches the ix35 Hydrogen Fuel Cell car in UK the Government put £11 million into hydrogen refuelling…

Prevention holds the key to a sustainable health service. NHS England must lead the way in highlighting the important…

Like the Great Barrier reef the Suffolk shingle bank is threatened by man and nature. It needs yearly maintenance…

AnswerTime®- a new WebTV format developed by InformationDaily.TV - invited Hazel Blears MP, Professor Olinga…

A Labour government will replace the House of Lords with an elected senate of the regions. This sounds like a…

UN Intergovernmental Panel on Climate Change says global carbon emissions must reduce 40-70% by 2050 and fall…

As the UN Intergovernmental Panel on Climate Change issues a stark warning on global warming and amid mounting…

Bristol's mayor asks neighbours to join it in combined authority; Tees Valley announces plans to do likewise;…